StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 19, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $386.01M, up 6.8% from the year before. Over ten years it grew 19.1% a year on average. The highest annual figure on record is $19.37B in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$386.01M+6.8%
FY2024Dec 31, 2024$361.37M-23.1%
FY2023Dec 31, 2023$470.17M-68.1%
FY2022Dec 31, 2022$1.47B-92.4%
FY2021Dec 31, 2021$19.37B+3692.5%
FY2020Dec 31, 2020$510.62M+107.5%
FY2019Dec 31, 2019$246.05M+7.1%
FY2018Dec 31, 2018$229.65M+31.7%
FY2017Dec 31, 2017$174.35M+140.7%
FY2016Dec 31, 2016$72.43M+7.4%
FY2015Dec 31, 2015$67.41M+7.1%
FY2014Dec 31, 2014$62.93M-12.3%
FY2013Dec 31, 2013$71.77M+45.8%
FY2012Dec 31, 2012$49.22M-13.4%
FY2011Dec 31, 2011$56.84M+70.2%
FY2010Dec 31, 2010$33.40M-60.3%
FY2009Dec 31, 2009$84.20M–

More Sinovac Biotech figures

See a number that looks wrong?